Catalyst Event
Huadian Power International Corp Ltd (1071) · Other
From Akros SCHK HK-Korea Quality Factor Index (ASHKQLT)
6/5/2026, 12:00:00 AM
Record date (2026-06-05) for the final dividend of RMB 0.14 per share for the year ended December 31, 2025, scheduled. The H-share register will be closed from June 3 to June 5, 2026, and the dividend is scheduled to be paid on July 28, 2026. Low impact estimated as dividend yield is typically stable and already priced in.
Korean Translation
2025년 12월 31일 마감 연도의 주당 0.14위안 최종 배당을 위한 배당기준일(2026-06-05)로 예정됨. H주 주주명부 폐쇄 기간은 2026년 6월 3일부터 6월 5일까지이며, 배당금 지급 예정일은 2026년 7월 28일임. 배당 수익률이 안정적이고 이미 주가에 반영되어 있어 낮은 영향이 예상됨.
Related Recent Events
China Nonferrous Mining Corp Ltd (1258) · Other
Ex-dividend date for the proposed final dividend of USD 0.041446 per share for the year ended December 31, 2025, scheduled for 2026-06-30. Dividend distributions typically result in a price impact of 1-5%.
6/30/2026, 12:00:00 AM
DB Insurance Co Ltd (005830) · Other
Issuance of up to KRW 600 billion in subordinated capital securities in June 2026 is scheduled. Capital base strengthening and debt refinancing justify a low neutral impact estimate scheduled.
6/1/2026, 12:00:00 AM
Hanmi Semiconductor Co Ltd (042700) · Earnings Release
Q1 2026 earnings release, with medium importance estimated due to expected volatility in semiconductor equipment stocks, is scheduled.
5/20/2026, 12:00:00 AM
DB Insurance Co Ltd (005830) · Earnings Release
Q1 2026 earnings release on May 15, 2026, is scheduled. Analysts forecast a potential year-over-year decline in net profit based on April 2026 estimates, justifying a medium negative impact scheduled.
5/15/2026, 12:00:00 AM
ANTA Sports Products Limited (2020) · Other
Final dividend of HKD 1.08 per share for the year ended December 31, 2025, with an ex-dividend date of May 15, 2026, and a payment date of June 1, 2026. This is estimated to have a low price impact of approximately 1.2% based on the dividend yield, scheduled.
5/15/2026, 12:00:00 AM
Alteogen Inc (196170) · Other
A US patent board invalidated a key patent of competitor Halozyme on May 14, 2026, reducing legal risks for Alteogen's partner Merck and leading to a significant stock price increase.
5/14/2026, 12:00:00 AM